Related Experiment Videos

Statistical designs for early phases of cancer clinical trials

Shanhong Guan1

  • 1Merck Research Laboratories, North Wales, PA 19454, USA. shanhong_guan@merck.com

Journal of Biopharmaceutical Statistics
|October 19, 2012
PubMed

Insights

This review discusses statistical designs for Phase I and Phase II cancer trials. It covers frequentist and Bayesian methods for determining safe dosing and effective cancer therapies, exploring efficient future trial designs.

Area of Science:

  • Oncology
  • Clinical Trials
  • Biostatistics

Background:

  • Phase I trials assess antitumor agent safety and dosing.
  • Phase II trials evaluate anticancer therapy efficacy against specific tumors.
  • Statistical design is crucial for robust clinical trial outcomes.

Purpose of the Study:

  • Review common statistical designs for Phase I and Phase II cancer trials.
  • Discuss frequentist and Bayesian methodologies in trial design.
  • Explore future directions for more efficient clinical trial designs.

Main Methods:

  • Review of statistical designs for cancer clinical trials.
  • Discussion of frequentist and Bayesian approaches.
  • Exploration of future trial design strategies.

Main Results:

  • Identified common statistical designs for early-phase cancer trials.
  • Compared frequentist and Bayesian methods in trial design.
  • Highlighted areas for improving trial efficiency.

Conclusions:

  • Statistical design is key to evaluating new antitumor agents.
  • Both frequentist and Bayesian methods are applicable to cancer trials.
  • Continued innovation in trial design can enhance drug development.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...